“Undoubtedly, next year we will continue to see research advances in the realm of Tissue Engineering/Regenerative Medicine (TERM),” says Hadjiargyrou, who specializes in molecular and cell biology, genetic engineering, biomaterials and stem cell research. “Specifically, we will witness the formation of more tissues and possibly even organs fabricated in the laboratory with the use of 3D printers (Bioprinters).”
Hadjiargyrou specifically identifies the heart valve, blood vessel, trachea, kidney, and liver, as the tissue or organs that will be printed with the use of 3D printers; kidneys, livers and hearts are most in demand.
“Additionally, the successful transplantation of some of these laboratory tissues and organs will be achieved, particularly in Europe, as they have been more active in transplantation of biomaterials. With the emergence of such breakthroughs, we will begin to see more and more clinical and even cosmetic applications of TERM.” Hadjiargyrou focuses on studying the molecular mechanisms involved in bone regeneration as a way to better understand the healing of fractures. Hadjiargyrou teaches general biology, genetic engineering, contemporary biotechnology and biomedical research in Old Westbury, NY.
RSS